C & C BIOPHARMA LLC has a total of 20 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are AHN GOOK PHARMACEUTICAL CO LTD, MEDWELL LAB LTD and LEONIDOV NIKOLAI B.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | China | 2 | |
#6 | Australia | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Acyclic or carbocyclic compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Chen Lin | 20 |
#2 | Wu Yongqing | 19 |
#3 | Chen Xiaojiang | 12 |
#4 | Gai Dahai | 11 |
#5 | Bishopric Nanette | 8 |
#6 | Xia Meng | 7 |
#7 | Wei Jian | 7 |
#8 | Chen Yongheng | 6 |
#9 | Ge Dahai | 1 |
#10 | Wei Jianqin | 1 |
Publication | Filing date | Title |
---|---|---|
US2015284360A1 | Amide derivatives of aniline-related compounds and compositions thereof | |
CA2929646A1 | Treatment of cardiac remodeling and other heart conditions | |
WO2014138507A1 | Treatment of cervical cancer and/or ovarian cancer using a transcription factor modulator | |
US2014256775A1 | Transcription factor modulators |